 FORT COLLINS, Colo., Aug. 10, 2021 PRNewswire -- Cytocom, Inc. NASDAQ: CBLI, a leading biopharmaceutical company creating next-generation immune therapies that focus on immune restoration and homeostasis, today announced that the Company will host a conference call and live audio webcast on Monday, August 16, 2021, at 8:30 a.m. 